Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 2/5/2025 | Mkt Perform → Outperform | William Blair | ||
| 2/3/2025 | $67.00 → $80.00 | Neutral → Outperform | Wedbush | |
| 9/4/2024 | $52.00 | Outperform → Neutral | Wedbush | |
| 3/25/2024 | $50.00 → $75.00 | Hold → Buy | Loop Capital | |
| 1/18/2024 | $41.00 → $61.00 | Neutral → Overweight | Piper Sandler | |
| 12/8/2023 | $45.00 | Outperform → Market Perform | TD Cowen | |
| 11/20/2023 | $25.00 | Neutral | JP Morgan | |
| 9/28/2023 | $33.00 | Overweight | Piper Sandler |
8-K - SOMNIGROUP INTERNATIONAL INC. (0001206264) (Filer)
8-K - SOMNIGROUP INTERNATIONAL INC. (0001206264) (Filer)
8-K - SOMNIGROUP INTERNATIONAL INC. (0001206264) (Filer)
Alto Neuroscience, Inc. ("Alto") (NYSE:ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the appointment of Raymond Sanchez, M.D., to its Board of Directors, effective August 12, 2025. Dr. Sanchez is a highly accomplished executive with a strong background in medicine and over 20 years of strategic experience in the life sciences industries. "We are delighted to welcome Ray to our Board of Directors as we continue advancing multiple clinical-stage precision psychiatry programs," said Amit Etkin, M.D., Ph.D., founder and chief executive officer of Alto Neuroscience. "Ray brings an impress
LEXINGTON, Ky., Feb. 18, 2025 /PRNewswire/ -- Somnigroup International Inc. (NYSE:SGI, ", Company", or ", Somnigroup", )), formerly Tempur Sealy International, today announced the completion of its name change. Shares of Somnigroup common stock trade on the New York Stock Exchange under the ticker symbol "SGI." Scott Thompson, Somnigroup Chairman and CEO said, "Somnigroup is the world's largest bedding company, with superior capabilities in design, manufacturing, distribution and retail while owning a portfolio of the most highly recognized brands in the industry. The name Somnigroup is derived from the Latin words "somn," meaning sleep, "omni," meaning all, and "group" to reflect our posit
- New Interim CEO of Mattress Firm, Scott Thompson LEXINGTON, Ky., Feb. 12, 2025 /PRNewswire/ -- Tempur Sealy International, Inc. (NYSE:TPX, ", Company", or ", Tempur Sealy", )) today announced management changes at Mattress Firm. The Company recently acquired Mattress Firm, the nation's largest mattress specialty retailer. John Eck has decided to step down as Chief Executive Officer of Mattress Firm. The Company has entered into a consulting agreement with Mr. Eck to ensure a smooth transition. Scott Thompson, Chairman and CEO of Tempur Sealy, will act as Interim CEO of Mattress Firm during a transition period. The Company expects to appoint a new CEO of Mattress Firm within the next 6 t
William Blair upgraded Tempur Sealy Int'l from Mkt Perform to Outperform
Wedbush upgraded Tempur Sealy Int'l from Neutral to Outperform and set a new price target of $80.00 from $67.00 previously
Wedbush downgraded Tempur Sealy Int'l from Outperform to Neutral and set a new price target of $52.00
4 - TEMPUR SEALY INTERNATIONAL, INC. (0001206264) (Issuer)
3 - TEMPUR SEALY INTERNATIONAL, INC. (0001206264) (Issuer)
4 - TEMPUR SEALY INTERNATIONAL, INC. (0001206264) (Issuer)
4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
4 - Cerevel Therapeutics Holdings, Inc. (0001805387) (Issuer)
Alto Neuroscience, Inc. ("Alto") (NYSE:ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the appointment of Raymond Sanchez, M.D., to its Board of Directors, effective August 12, 2025. Dr. Sanchez is a highly accomplished executive with a strong background in medicine and over 20 years of strategic experience in the life sciences industries. "We are delighted to welcome Ray to our Board of Directors as we continue advancing multiple clinical-stage precision psychiatry programs," said Amit Etkin, M.D., Ph.D., founder and chief executive officer of Alto Neuroscience. "Ray brings an impress
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") announced today that Evelyn Dilsaver has been appointed to serve as a member of its Board of Directors. "We're thrilled to have Evelyn join our board," said Jason Murray, PACS Chairman and CEO. "She has great experience as an accounting and finance professional, not to mention her work on the boards of several other public companies. She'll bring added perspective and expertise to the board as we work to guide PACS going forward." "I'm excited to join the PACS Board and assist the company in continuing its mission to provide quality skilled nursing care. I look forward to great things ahead for the company," added Ms. Dilsaver. Ms.
Mr. Burgess will be responsible for leading Cerevel's business development and quality teams Mr. Burgess to join Cerevel effective June 20, 2023 CAMBRIDGE, Mass., June 15, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (NASDAQ:CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced the appointment of Paul Burgess as chief business development and strategic operations officer, effective June 20, 2023. "I am so pleased to welcome Paul to Cerevel as our chief business development and strategic operations officer, with his proven track record of success in the biotech and pharmaceutical industry," said Ron Renaud, president and chie
- Announces Tempur Sealy International, Inc to Change its Name to Somnigroup International Inc., Reflecting Acceleration of Omni-Channel Strategy- Hosting Business Update Call on February 6, 2025 LEXINGTON, Ky., Feb. 5, 2025 /PRNewswire/ -- Tempur Sealy International, Inc. (NYSE:TPX, ", Company", or ", Tempur Sealy", )) today announced that it has completed its previously announced acquisition of Mattress Firm Group Inc. ("Mattress Firm"), the nation's largest mattress specialty retailer. In a separate release today, the Company announced it will change its name to Somnigroup International Inc. ("Somnigroup"), effective February 18, 2025. Mattress Firm, Dreams and Tempur Sealy will operat
LEXINGTON, Ky., Feb. 4, 2025 /PRNewswire/ -- Tempur Sealy International, Inc. (NYSE:TPX, ", Company", or ", Tempur Sealy", )) announced today that it expects to close its previously announced acquisition of Mattress Firm Group Inc. ("Mattress Firm"), the nation's largest mattress specialty retailer, on Wednesday, February 5, 2025. This follows the ruling from the United States District Court for the Southern District of Texas denying the motion by the Federal Trade Commission ("FTC") for a preliminary injunction to halt the closing of the proposed acquisition. The FTC has indicated that it will not seek emergency relief from the Fifth Circuit and will not prevent the transaction from closing
LEXINGTON, Ky., Jan. 15, 2025 /PRNewswire/ -- Tempur Sealy International, Inc. (NYSE:TPX) will release its financial results for the fourth quarter and full year ended December 31, 2024, before the NYSE opening of regular trading on Thursday, February 20, 2025. The Company will hold a conference call at 8:00 a.m. Eastern Time. The call will be webcast and can be accessed on the Company's investor relations website at investor.tempursealy.com. After the conference call, a webcast replay will remain available on the website for 30 days. About the Company Tempur Sealy is committed to improving the sleep of more people, every night, all around the world. As a leading designer, manufacturer, dis
SC 13D/A - Cerevel Therapeutics Holdings, Inc. (0001805387) (Subject)
SC 13D/A - Cerevel Therapeutics Holdings, Inc. (0001805387) (Subject)
SC 13G/A - Cerevel Therapeutics Holdings, Inc. (0001805387) (Subject)